Journal Article Reprint Payments Reported In Sunshine Database Should Be “Put Into Context,” Sen. Grassley Says
This article was originally published in The Gray Sheet
Executive Summary
Sen. Chuck Grassley, R-Iowa, April 10 pressed HHS Secretary Sebelius to be certain that financial data reported by device and drug companies to the forthcoming Open Payments database tied to the value of medical journal article reprints be put into context.
You may also be interested in...
Companies Dig Into Sunshine Rule Details In Preparation For Aug. 1 Go-Live Date
CMS has finalized several sunshine rule provisions: the definition of “applicable manufacturer” has been narrowed; many payments to speakers at continuing medical education programs and events need not be reported; and the agency will allow manufacturers to supply contextual information on the public database.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.